COSMOS Pharmaceutical

#3822

Rank

$3.27B

Marketcap

Japan

Country

Leadership team

Mr. Mauro Severino Ajani (Founder & Exec. Chairman)

Mr. Ngo Dinh Nhan (Head of R&D - AI & Biomedical IT)

Mr. Alessandro E. Della Cha LL.M (CEO & Exec. Director)

Products/ Services

Biotechnology, Health Care, Manufacturing, Pharmaceutical

Number of Employees

1,000 - 20,000

Headquarters

Dublin, Dublin, Ireland

Established

1996

Net Income

100M - 500M

Revenue

Above - 1B

Traded as

3349.T

Social Media

URL

https://www.cosmopharma.com

Overview

Location

Recognition and Award

References

Summary

Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diagnostic drug to enhance pre-cancerous and cancerous detection of colorectal lesions during colonoscopy. The company also provides Eleview, an injectable composition for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers, or other gastrointestinal mucosal lesions; Aemcolo/Relafalk, a pharmaceutical product used for the treatment of traveler's diarrhea, uncomplicated acute diverticulitis, minimal hepatic encephalopathy, and small intestine bacterial overgrowth; and Winlevi, an androgen receptor inhibitor for acne vulgaris. In addition, it offers Clascoterone, an androgen receptor inhibitor that targets in the scalp and androgenetic alopecia; Rifamycin for irritable bowel syndrome with diarrhoea; ByFavo (Remimazolam), a fast-acting intravenous benzodiazepine agent for procedural sedation; CB-03-10, an oral androgen receptor antagonist for treatment against solid tumors; CB-01-33 for bile acid diarrhea; and Qolotag, a single use enema formulation. The company has a license agreement with RedHill Biopharma Ltd.; and Acacia Pharma Group plc. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland.

History

The story of COSMOS Pharmaceuticals begins in the early 2000s when a start-up led by a small team of innovative scientists created a pharmaceutical-focused business model. This model has allowed the company to quickly develop into one of the most trusted names in post-sales pharma care. COSMOS Pharmaceuticals has been at the forefront of developing and delivering quality pharmaceutical products ever since.

Mission

As the cosmos flowers firmly root in the wilderness and bloom beautiful flowers, one store that our company develops is firmly rooted in that land, "providing rich living for the regional customers

Vision

As the cosmos flowers firmly root in the wilderness and bloom beautiful flowers, one store that our company develops is firmly rooted in that land, "providing rich living for the regional customers

Key Team

Ms. Hazel Winchester (Head of Investor Relations)

Mr. Biagio Vigano (Chief People Officer)

Mr. Giulio Evangelisti (Head of Production, AI & Biomedical IT)

Mr. Niall Donnelly (Chief Financial Officer)

Mr. Marco Lecchi (Chief Operating Officer)

Mr. Davide Malavasi (Qualified Person & Technical Director)

Mr. Luigi Longo (Chief Scientific Officer)

Recognition and Awards

Since its establishment in 2004, COSMOS Pharmaceuticals has been recognized numerous times for its excellence in quality and customer service. The company has received numerous awards, including the Pharmacy of the Year award from the New York State Pharmacists Association.